Clinical Trial Update: Tranexamic Acid to Reduce Blood Loss in Hemorrhagic Caesarean Delivery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating tranexamic acid to reduce blood loss in hemorrhagic cesarean delivery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstetric Hemorrhage

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: University Hospital, Lille | Conditions: Pregnancy Complications, Hemorrhage | Phase 4 | Status: COMPLETED